What is the appropriate acute management for a patient presenting with a heart rate of 190 bpm and brief chest discomfort that diminishes after the tachycardia resolves?

Acute Management of Tachycardia at 190 bpm with Chest Discomfort

If the tachycardia has already spontaneously resolved by the time you are evaluating this patient, obtain a 12-lead ECG immediately to look for pre-excitation (delta waves) and perform cardiac biomarker testing (troponin) to evaluate for myocardial injury from the episode. The chest discomfort persisting after rhythm conversion suggests possible demand ischemia during the tachycardia.

Critical Initial Assessment

First, determine if this was likely supraventricular tachycardia (SVT) versus ventricular tachycardia:

• SVT characteristics: Regular rhythm, narrow QRS complex (<120 ms), rate typically 150-250 bpm, abrupt onset/offset 1, 2
• Check for pre-excitation: Look for delta waves on baseline ECG - this changes management completely 3
• Hemodynamic status: The presence of chest discomfort raises concern but does not automatically mean instability

If Tachycardia Recurs or Patient Presents During Episode

For Hemodynamically Stable Patients (Most Likely Scenario)

The algorithmic approach is:

1. Vagal maneuvers FIRST (Class I recommendation) 3, 4:

   • Modified Valsalva maneuver: Patient supine, bear down against closed glottis for 10-30 seconds (equivalent to 30-40 mmHg pressure)
   • Success rate only 27.7% but should be attempted immediately as it's safe and quick 3
   • Carotid massage (after confirming no bruit): 5-10 seconds of steady pressure
   • Ice-cold wet towel to face (diving reflex)

2. IV Adenosine if vagal maneuvers fail (Class I recommendation) 3, 4:

   • 90-95% effective for terminating SVT 3, 4
   • Administer as rapid bolus via proximal IV followed immediately by saline flush
   • Critical caveat: Have cardioversion equipment immediately available - adenosine can precipitate atrial fibrillation that may conduct rapidly, especially if accessory pathway present 3
   • Common transient side effects (<1 min): chest discomfort, dyspnea, flushing in ~30% of patients 3

3. IV calcium channel blockers if adenosine fails or recurs (Class IIa recommendation) 3, 4:

   • Diltiazem or verapamil: 64-98% effective for SVT termination 3
   • Absolute contraindications: Do NOT use if any possibility of pre-excited atrial fibrillation (wide complex irregular tachycardia) - can cause ventricular fibrillation 3, 4
   • Avoid in suspected systolic heart failure 4
   • Slow infusion over 20 minutes reduces hypotension risk 3

4. IV beta blockers are reasonable alternative (Class IIa) 4:

   • Less effective than calcium channel blockers but excellent safety profile
   • Reasonable choice if calcium channel blockers contraindicated

5. Synchronized cardioversion if medications fail (Class I recommendation) 3:

   • Requires sedation/anesthesia in stable patients
   • Highly effective for terminating SVT 3

For Hemodynamically Unstable Patients

Synchronized cardioversion immediately (Class I recommendation) 3:

• Hemodynamic instability defined as: hypotension, acutely altered mental status, signs of shock, ongoing chest pain, acute heart failure 3
• The 2010 ACLS guidelines recommend considering adenosine first even in unstable patients if tachycardia is regular narrow-complex, but cardioversion should not be delayed if adenosine unavailable 3

Critical Pitfalls to Avoid

1. Pre-excitation (WPW) with atrial fibrillation: If you see wide, irregular QRS complexes at 190 bpm, this is pre-excited AF, NOT typical SVT:

   • DO NOT give adenosine, calcium channel blockers, beta blockers, or digoxin - these can accelerate conduction and cause ventricular fibrillation 3
   • Immediate cardioversion if unstable 3
   • If stable: IV procainamide or ibutilide 3

2. Ventricular tachycardia masquerading as SVT: Always obtain 12-lead ECG, not just single-lead monitor 2

3. Chest discomfort during SVT: This patient's chest discomfort likely represents demand ischemia from the rapid rate. After conversion:

   • Check troponin to assess for myocardial injury
   • Consider stress testing or coronary evaluation if troponin elevated or symptoms persist
   • The discomfort persisting after conversion is concerning and warrants further evaluation

Post-Conversion Management

After successful conversion:

• Obtain 12-lead ECG looking specifically for delta waves (pre-excitation) 3
• Check troponin given the chest discomfort 1
• Watch for premature atrial/ventricular complexes that may reinitiate tachycardia - may need antiarrhythmic to prevent recurrence 3
• Refer for electrophysiology evaluation and catheter ablation: This is first-line definitive therapy with 94.3-98.5% single-procedure success rate 1

Long-Term Prevention

Catheter ablation is the most effective therapy and should be offered as first-line treatment for recurrent symptomatic PSVT (success rate 94-98%) 1. Pharmacologic options (beta blockers, calcium channel blockers) are less effective and reserved for patients who decline or are not candidates for ablation 3, 1.